Note- old diseases and conditions continue to return, such

New Post Public Reply Private Reply Replies (2) Message Board
microcaps microcaps #5594
499
Note- old diseases and conditions continue to return, such as tb, measles etc. The bubonic plague itself continues to affect Americans. e.g.,https://www.scientificamerican.com/article/100-years-of-bubonic-plague/
Plus a panoply of new diseases/conditions will continue to grow as per many sources-so whether or not NNLX's N-assay is used for the current pandemic, the N -assay will continue to be useful against a wide range of bacterial and viral conditions in the future,as NNLX has noted, especially in comparison to the more limited diagnosis afforded by the current pcr or pcp tech.

And yes, the govt contractor -whoever they are -who showed an interest in NNLX's N- assay -as per a preliminary agreement- is not likely to disappear in a week or two. I've explained ad nauseum in the past why it takes so long for things to move forward,given the required dd and communication among several disparate specialized groups who do not speak the same language.


almost all drugs have side effects and become toxic at some level of dosage. E.g., I've read that acetaminophen can cause liver failure at just 4000 mg/day (in fact in some cases as low as 2000mg/day i think i've read)=-bottles say do not exceed 4000mg/day or use with certain other drugs or take 3 or more alcoholic drinks/day. Untreated liver failure results in death.

https://www.uspharmacist.com/article/acetamin...ed-to-know

from the cited article: Acetaminophen toxicity is one of the most common causes of both intentional and unintentional poisoning in the U.S. In fact, there has been a steady increase in the incidence of acetaminophen-related toxicity over the past decade.... Acetaminophen-associated overdoses account for approximately 56,000 emergency department visits, 26,000 hospitalizations, and over 450 deaths annually.9

if such a commonly used drug as acetaminophen is so toxic then its odd that a reported side effect in just ONE wrong self diagnosed self treating patient was used in one article https://fortune.com/2020/03/20/malaria-drug-c...dly-china/ to caution against chloroquine treatment for covid 19- such a strange event/article title is more likely part of current widespread political assassination attempts.

the ff was the journal article cited by my post
https://www.sciencedirect.com/science/article...via%3Dihub

https://www.ncbi.nlm.nih.gov/pubmed/32164085
the wiki article https://en.wikipedia.org/wiki/Chloroquine notes that
a further study concluded that hydroxychloroquine was more potent than chloroquine, with a more tolerable safety profile

one article said the older less safe form of chloroquine was widely used by europeans before entering any malaria prone theater and that said europeans continued on a dosage of such for 2 months AFTER exiting malaria prone areas. Obviously- even the older less safe form of the treatment were considered an improvement compared to malaria.

Of course, today safety is emphasized more than decades ago,but in all cases drugs are intended for particular uses under a doctors direction- and are not to be used willy nilly as per a wrong self diagnosis as did the chinese woman who developed arrhythmia- which is contraindicated for chloroquine, just as a long list of drugs are contraindicated for those with heart problems. In most such cases it is the side effect which kills -often in people prone to such a side effect.
In italy i've read that up to 99% of deaths occurred in those with a previous underlying medical condition.
As French and Australian and Chinese work with chloroquine (which was also effective against some previous corona viruses) and its safer derivatives came to light it was naturally jumped on as a possible treatment modality, and it still is, since regulatory approval for all potential vaccines seems to be one year away, according to reports i've read and heard.

So non-scientists, including politicians, will in the current climate of runaway fear be glad to push such a potential treatment.
That is part of their job to calm fears in a fear prone populace.

Meanwhile scientists,who by nature must be more cautious -want to look at the studies first and determine whether other studies or tests are necessary for safety purposes before jumping into the boat. This paradigm should be well known and understood-and remember it was scientists use of chloroquine or its safer derivatives and their scientific statements that such use was highly effective against the virus in their studies/samples that got politicians and others excited,as it should-why -because we cannot idly sit by and wait one year for a vaccine to be approved before we start to combat the virus. That should be obvious.



Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 9

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading

Top 5 Most Recently Viewed Articles

UK Jobless Claims Show Promise, but Wage Growth Slows Down

Updated Category News Views 73

UK Jobless Claims Show a Milder Rise Jobless claims in the UK rose by 23.7K in August. That’s a much smaller increase than the 95.5K many expected and below the 102.3K jump recorded the month before. The takeaway: while claims are still climbing, the pace of deterioration looks less severe than feared, hinting that the labor market’s slide may be slowing. Why It...

Continue Reading
Celebrating 130 Years of Dedicated Service to Military Families

Updated Category News Views 142

Celebrating 130 Years of Dedicated Service The Army & Air Force Exchange Service has reached a significant milestone as it celebrates its 130th anniversary of supporting those who serve. This remarkable journey began in 1895 when the U.S. Department of War's General Orders established the need for a post exchange (PX) for military members. Over the decades, the Exchange...

Continue Reading
The Surge of In Vitro Diagnostics: A Market Worth Billions

Updated Category News Views 80

Introduction to the Growing IVD Market As we delve into the world of healthcare, the In Vitro Diagnostics (IVD) market stands out vividly. Based on insights from industry sources, this growing sector was valued at USD 83.04 billion in 2023. Projections indicate that it could swell to a remarkable USD 126.6 billion by the start of the next decade, marking a steady compound...

Continue Reading
Boeing Considers Strategic Shift with Space Business Sale

Updated Category News Views 198

Boeing's Strategic Evaluation of Its Space Ventures Boeing (NYSE: BA) is currently assessing the possibility of divesting its space operations, according to reports from credible sources. This evaluation aligns with the company's broader strategy to focus on more lucrative segments of its business while addressing challenges faced within its space sector. Details of the...

Continue Reading
Anthropic Enhances AI Capabilities with Google Cloud Partnership

Updated Category News Views 281

Anthropic's Strategic Partnership with Google Cloud Anthropic is making strides in artificial intelligence, recently announcing a significant expansion of its partnership with Google Cloud. The company plans to train and serve its Claude models using Google Cloud's TPU (Tensor Processing Unit) technology, which allows for enhanced machine learning capabilities. This...

Continue Reading